Discover 1,283 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,283
Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
for
Graft Failure
Location: Denver CO
Sponsor: Colorado Blood Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT00472329
Phase 2, Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
for
Lung Neoplasms
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT01580982
Recruiting
A Study of BG-C477 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Aurora CO, Westwood KS, Goodyear AZ, Longview TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06596473
Phase 1, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Aurora CO, Englewood CO, Salt Lake City UT, Murray UT,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase 3, Recruiting
A Study of EBC-129 in Advanced Solid Tumours
for
Advanced Solid Tumours
Location: Aurora CO, Houston TX
Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Sex: All
Age: 18+
Code: NCT05701527
Phase 1, Recruiting
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
for
Lung Cancer, NSCLC, Brain Metastases
Location: Aurora CO, Stanford CA, Columbus OH
Sponsor: Joshua Palmer
Sex: All
Age: 18+
Code: NCT05987644
Phase 1, Phase 2, Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Aurora CO, West Valley City UT, St Louis MO, Houston TX,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
for
Colorectal Cancer
Location: Aurora CO, Highlands Ranch CO, Texas City TX,
Sponsor: Kahr Bio Australia Pty Ltd
Sex: All
Age: 18+
Code: NCT07235293
Phase 2, Recruiting
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Aurora CO, Iowa City IA, Los Angeles CA,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07287150
Phase 2, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Aurora CO, Denver CO, Salt Lake City UT, Phoenix AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Aurora CO, Rochester MN, Los Angeles CA, Houston TX,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Aurora CO, Dallas TX, Glendale CA, San Antonio TX,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Aurora CO, Salt Lake City UT, Scottsdale AZ,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase 2, Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer